# Understanding Allergic Rhinitis

## Overview of Allergic Rhinitis

Allergic rhinitis (AR) is a pervasive health issue affecting over 400 million individuals worldwide. It presents with a variety of nasal and ocular symptoms, including:

### Nasal Symptoms
– Rhinorrhea
– Sneezing
– Itching
– Congestion
– Postnasal drip (PND)
– Snoring
– Mouth breathing
– Loss of taste or smell

### Ocular Symptoms
– Itching
– Redness
– Tearing
– Wet eyes

Approximately 90% of patients experience nasal congestion, often considered the most bothersome symptom and a major contributor to sleep disturbances related to rhinitis.

## Management of Allergic Rhinitis

### Importance of Symptom Relief

Symptom relief is fundamental to the management of AR. Pharmacological therapies that reduce inflammatory mediators can alleviate nasal congestion while enhancing sleep quality and overall quality of life. However, monotherapy often proves inadequate due to incomplete symptom control and poor adherence.

### Fexofenadine-Pseudoephedrine Combination

The fexofenadine-pseudoephedrine combination addresses these limitations by targeting both histaminic and congestive symptoms while preserving cognitive function through its non-brain-interfering antihistamine component.

## Tackling Nasal Congestion in Allergic Rhinitis

### Mechanisms of Action

While histamine is the primary mediator of most AR symptoms, it is not the main contributor to nasal congestion. Mast-cell mediators, particularly leukotrienes (LTC4, LTD4, and LTE4) and prostaglandin D2, play a significant role in nasal congestion. Therefore, combinations of an oral antihistamine with an oral decongestant are utilized to manage the full spectrum of AR symptoms, including:

– Pruritus
– Rhinorrhea
– Nasal congestion

### Benefits of Second-Generation Antihistamines

Second-generation oral antihistamines are fast-acting, long-lasting, and well-tolerated, ensuring improved compliance. Oral decongestants, especially in extended-release formulations, provide sustained relief of nasal congestion for 12-24 hours by activating adrenergic receptors, leading to vasoconstriction in the nasal mucosa, thereby improving airflow and reducing mucosal edema.

## The Fexofenadine-Pseudoephedrine Combination: A Newer Option in India

### Pharmacological Profile

Fexofenadine is an inverse agonist that exhibits antihistaminic effects by binding to the inactive form of the H1 receptor. It occupies over 90% of histamine H1 receptors within less than one hour, with a binding residence time over 100-fold greater than that of diphenhydramine, demonstrating very rapid binding kinetics. Notably, fexofenadine is a non-brain-interfering antihistamine that preserves cognitive and psychomotor functions, even at higher than recommended doses.

### Role of Pseudoephedrine

Pseudoephedrine, a widely used decongestant in combination products, effectively alleviates nasal congestion with a well-documented safety profile. It narrows the blood vessels in swollen nasal mucous membranes, thereby reducing tissue hyperemia, edema, and nasal congestion, which facilitates the drainage of sinus secretions. The combination formulation of fexofenadine HCl 180 mg and pseudoephedrine HCl 240 mg is indicated for adults and children aged 12 years and older for relief from allergic rhinitis symptoms.

## Clinical Evidence on Fexofenadine and Pseudoephedrine Combination

### Clinical Study Overview

A multicenter, double-blind, parallel-group study randomized 651 patients with seasonal allergic rhinitis (allergic to ragweed) to receive one of the following treatments for two weeks:

– Fexofenadine 60 mg twice daily
– Sustained-release pseudoephedrine 120 mg twice daily
– A combination of both drugs twice daily

### Results of Combination Therapy

Combination therapy significantly reduced histamine-mediated symptoms, including:

– Sneezing
– Rhinorrhea
– Itchy nose/palate/throat
– Itchy/watery/red eyes

The study results underscored the effectiveness of the fexofenadine-pseudoephedrine combination in managing allergic rhinitis symptoms.